| P2093 | author name string | John J Castellot | |
| | Caitlin Fujisawa | |
| P2860 | cites work | Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta | Q24290740 |
| | Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation | Q24307536 |
| | 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model | Q24632275 |
| | TGF-β signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation | Q26859137 |
| | Epidermal growth factor, from gene organization to bedside | Q26865616 |
| | Myofibroblasts and mechano-regulation of connective tissue remodelling | Q28216468 |
| | The role of the hormone relaxin in human reproduction and pelvic girdle relaxation | Q28271851 |
| | Negative regulation of transforming growth factor-beta by the proteoglycan decorin | Q28292224 |
| | Regulation of type I collagen genes expression | Q28295942 |
| | An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas | Q28487526 |
| | Structure and function of platelet-derived growth factor (PDGF) and related proteins | Q28645852 |
| | Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids | Q29347067 |
| | Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies | Q29614313 |
| | Fibroblast growth factor signalling: from development to cancer | Q29616827 |
| | Friends or foes - bipolar effects of the tumour stroma in cancer | Q29619348 |
| | Uterine fibroids: current perspectives | Q30443242 |
| | Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice | Q33712325 |
| | Insulin-like growth factor 1 (IGF-1): a growth hormone | Q33918809 |
| | High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence | Q33963976 |
| | Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture | Q33964731 |
| | Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium | Q34064015 |
| | Integrin β1 regulates leiomyoma cytoskeletal integrity and growth | Q34084035 |
| | Gene expression analysis reveals an angiogenic profile in uterine leiomyoma pseudocapsule | Q53102062 |
| | The promotion of neural progenitor cells proliferation by aligned and randomly oriented collagen nanofibers through β1 integrin/MAPK signaling pathway. | Q53238852 |
| | Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing | Q53528097 |
| | In-vitro model of uterine leiomyomas: formation of ball-like aggregates. | Q53619349 |
| | Gene expression patterns of insulin-like growth factor 2 in human uterine fibroid tissues: a genetic study with clinical correlations. | Q54268670 |
| | Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas. | Q54535265 |
| | A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. | Q54608831 |
| | Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race | Q57751559 |
| | Vitamin D Status in Women With Uterine Leiomyomas | Q58860606 |
| | Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women | Q68194610 |
| | Growth factors and cancer | Q70121988 |
| | Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells | Q71985176 |
| | Growth factors in the extracellular matrix | Q73075408 |
| | A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis | Q73370347 |
| | Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding | Q73691408 |
| | Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth | Q77763549 |
| | A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata | Q79791604 |
| | Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression | Q80974809 |
| | Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth | Q81155526 |
| | Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium | Q81456048 |
| | Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata | Q81492992 |
| | Downregulation of the integrin α(v) signaling pathway in uterine leiomyomas | Q82847592 |
| | Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition | Q83274494 |
| | Vitamin d and the risk of uterine fibroids | Q37671721 |
| | The cell biology of transforming growth factor beta | Q37938405 |
| | Vitamin A and its derivatives in experimental photocarcinogenesis: preventive effects and relevance to humans | Q38105002 |
| | Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present. | Q38175443 |
| | Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 | Q38291995 |
| | Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen | Q38295371 |
| | Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling | Q38321757 |
| | Down-regulation of collagen synthesis and matrix metalloproteinase expression in myofibroblasts from Dupuytren nodule using adenovirus-mediated relaxin gene therapy. | Q38443986 |
| | Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports | Q39255950 |
| | Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms | Q39271323 |
| | 2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells | Q39349826 |
| | Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3. | Q39867260 |
| | AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling | Q40079062 |
| | Src and focal adhesion kinase mediate mechanical strain-induced proliferation and ERK1/2 phosphorylation in human H441 pulmonary epithelial cells | Q40184472 |
| | Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. | Q40407111 |
| | Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds | Q40416112 |
| | Wounding induces motility in sheets of corneal epithelial cells through loss of spatial constraints: role of heparin-binding epidermal growth factor-like growth factor signaling | Q40574655 |
| | Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases | Q40594336 |
| | The expression of integrins and cadherins in normal human uterus and uterine leiomyomas | Q41180472 |
| | Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata | Q41660451 |
| | Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts | Q41955517 |
| | Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. | Q42492565 |
| | Fibronectin Growth Factor-Binding Domains Are Required for Fibroblast Survival | Q42825954 |
| | Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells | Q42939335 |
| | Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life | Q43469535 |
| | Identification, quantification and fine structural characterization of glycosaminoglycans from uterine leiomyoma and normal myometrium | Q43708391 |
| | Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells | Q43794640 |
| | Dysregulation of IGF-I signaling in uterine leiomyoma | Q43851259 |
| | Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis | Q44104200 |
| | A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts | Q44243144 |
| | Expression of procollagen C‐proteinase enhancer in cultured rat heart fibroblasts: Evidence for co‐regulation with type I collagen | Q44593470 |
| | Insulin-like growth factor II messenger RNA-binding protein 3 expression in gastrointestinal mesenchymal tumors | Q44771161 |
| | The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling | Q44908928 |
| | Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells | Q46370773 |
| | Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. | Q46539035 |
| | Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer | Q46748582 |
| | Effects of human epidermal growth factor gene-transfected mesenchymal stem cells on fibroblast migration and proliferation | Q47976863 |
| | Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. | Q47990803 |
| | Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent. | Q50916738 |
| | Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production. | Q50918854 |
| | Overexpression of integrin-β1 in leiomyoma promotes cell spreading and proliferation. | Q52639069 |
| | Fibronectin at a glance | Q34150530 |
| | The role of the IGF system in cancer: from basic to clinical studies and clinical applications | Q34157884 |
| | Molecular genetics and racial disparities of uterine leiomyomas | Q34228266 |
| | Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase | Q34354106 |
| | 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells | Q34758625 |
| | Extracellular matrix collagen alters cell proliferation and cell cycle progression of human uterine leiomyoma smooth muscle cells | Q34990653 |
| | Measurement of phenolic environmental estrogens in women with uterine leiomyoma | Q35047452 |
| | Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells | Q35087174 |
| | Integrin signaling to the actin cytoskeleton. | Q35547365 |
| | Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems | Q35606164 |
| | Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis | Q35792203 |
| | The estimated annual cost of uterine leiomyomata in the United States | Q35798693 |
| | Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women | Q35927830 |
| | Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances | Q36198889 |
| | Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix | Q36220283 |
| | Immunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle | Q36230444 |
| | Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | Q36232491 |
| | Fibronectin binding site in type I collagen regulates fibronectin fibril formation | Q36232898 |
| | Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells | Q36326856 |
| | The genetic heterogeneity of uterine leiomyomata | Q36407931 |
| | Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas | Q36409237 |
| | Human prolyl hydroxylase expression in uterine leiomyoma during the menstrual cycle | Q36594429 |
| | Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma | Q36620511 |
| | Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration | Q36631516 |
| | Insulin-like growth factor binding proteins: roles in regulating IGF physiology | Q36670514 |
| | Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix | Q36712745 |
| | A tense situation: forcing tumour progression | Q37112264 |
| | Progestins activate the AKT pathway in leiomyoma cells and promote survival. | Q37198021 |
| | Mechanical homeostasis is altered in uterine leiomyoma | Q37227767 |
| | Complex interactions between dietary and genetic factors impact lycopene metabolism and distribution | Q37282026 |
| | Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth | Q37369748 |
| | Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. | Q37375061 |
| | Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? | Q37378063 |
| | Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein | Q37399155 |
| P433 | issue | 3 | |
| P921 | main subject | leiomyoma | Q4667534 |
| P304 | page(s) | 179-194 | |
| P577 | publication date | 2014-07-11 | |
| P1433 | published in | Journal of Cell Communication and Signaling | Q26841964 |
| P1476 | title | Matrix production and remodeling as therapeutic targets for uterine leiomyoma | |
| P478 | volume | 8 | |